Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1BE0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,220
Award facts
- Contract value 100% obligated
- $56,219.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $56,219.85 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2mL pen injections. This is a firm fixed-price contract with an ultimate completion date of February 5, 2026, and represents a non-set-aside, competitively awarded delivery order. The product will be performed and delivered from the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This prime IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract supports various federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's established capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F1BE0?
SPE2DR26F1BE0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F1BE0 worth?
The government has obligated $56,220 on SPE2DR26F1BE0.
Is contract SPE2DR26F1BE0 an order under another contract?
Yes. SPE2DR26F1BE0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1BE0 competed?
The extent of competition for SPE2DR26F1BE0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award